Allergic diseases in children, including asthma, atopic dermatitis, allergic rhinitis, and food allergies, are increasingly prevalent worldwide and pose significant challenges to pediatric healthcare. Effective management requires modern pharmacological strategies, including antihistamines, corticosteroids, bronchodilators, leukotriene receptor antagonists, biologics, and allergen immunotherapy. This article reviews current approaches to pediatric allergy treatment, emphasizing individualized therapy, early intervention, and patient-centered care. The integration of evidence-based pharmacological interventions with education and trigger avoidance improves disease control, prevents complications, and enhances children’s quality of life.

pediatric allergy, pharmacology, allergen immunotherapy, asthma, atopic dermatitis, individualized treatment.

Pawankar, R., Canonica, G. W., Holgate, S. T., & Lockey, R. F. (2019). Allergic Diseases and Asthma: A Global Public Health Concern. World Allergy Organization Journal, 12(1), 100038.

Muraro, A., Werfel, T., Beyer, K., et al. (2022). EAACI Guidelines on Allergen Immunotherapy: Pediatric Considerations. Allergy, 77(4), 1131–1150.

Galli, S. J., Tsai, M., & Piliponsky, A. M. (2020). The Development of Allergic Diseases in Children: Mechanisms and Therapeutic Implications. Nature Reviews Immunology, 20, 125–138.

Bousquet, J., Schünemann, H. J., Togias, A., et al. (2020). Allergic Rhinitis and Its Impact on Asthma (ARIA) Guidelines – Pediatric Update. Allergy, 75(7), 1592–1623.

Castro-Rodriguez, J. A., & Rodrigo, G. J. (2021). Pharmacologic Management of Pediatric Asthma: Evidence-Based Updates. Pediatric Drugs, 23,